In numerous potential targets, FOXO3 was selected for further analysis as it has been reported to be closely associated with lipid metabolism and insulin resistance in HFD-induced NAFLD (Zhu et al., 2017). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.